nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2B6—Irinotecan—colon cancer	0.133	0.237	CbGbCtD
Ticlopidine—CYP2C9—Capecitabine—colon cancer	0.114	0.202	CbGbCtD
Ticlopidine—MPO—superior mesenteric artery—colon cancer	0.105	0.509	CbGeAlD
Ticlopidine—CYP2C8—Fluorouracil—colon cancer	0.0968	0.172	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—colon cancer	0.0749	0.133	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—colon cancer	0.0675	0.12	CbGbCtD
Ticlopidine—CYP3A4—Irinotecan—colon cancer	0.0409	0.0727	CbGbCtD
Ticlopidine—CYP3A4—Vincristine—colon cancer	0.0357	0.0635	CbGbCtD
Ticlopidine—Leukaemia—Vincristine—colon cancer	0.0116	0.0515	CcSEcCtD
Ticlopidine—P2RY12—epithelium—colon cancer	0.0097	0.047	CbGeAlD
Ticlopidine—MPO—endothelium—colon cancer	0.00948	0.0459	CbGeAlD
Ticlopidine—MPO—blood vessel—colon cancer	0.00874	0.0424	CbGeAlD
Ticlopidine—Diarrhoea haemorrhagic—Capecitabine—colon cancer	0.00806	0.0358	CcSEcCtD
Ticlopidine—Alveolitis allergic—Methotrexate—colon cancer	0.00581	0.0258	CcSEcCtD
Ticlopidine—Clopidogrel—ABCB1—colon cancer	0.0058	1	CrCbGaD
Ticlopidine—Leukaemia—Methotrexate—colon cancer	0.00563	0.025	CcSEcCtD
Ticlopidine—Bone marrow depression—Vincristine—colon cancer	0.00463	0.0205	CcSEcCtD
Ticlopidine—Lung disorder—Irinotecan—colon cancer	0.0043	0.0191	CcSEcCtD
Ticlopidine—MPO—epithelium—colon cancer	0.00426	0.0206	CbGeAlD
Ticlopidine—MPO—renal system—colon cancer	0.00395	0.0191	CbGeAlD
Ticlopidine—MPO—lymphoid tissue—colon cancer	0.00328	0.0159	CbGeAlD
Ticlopidine—MPO—digestive system—colon cancer	0.00324	0.0157	CbGeAlD
Ticlopidine—Nephropathy—Methotrexate—colon cancer	0.00318	0.0141	CcSEcCtD
Ticlopidine—Bone marrow depression—Capecitabine—colon cancer	0.00302	0.0134	CcSEcCtD
Ticlopidine—MPO—bone marrow—colon cancer	0.00298	0.0145	CbGeAlD
Ticlopidine—Colitis—Irinotecan—colon cancer	0.00292	0.013	CcSEcCtD
Ticlopidine—Sepsis—Irinotecan—colon cancer	0.00264	0.0117	CcSEcCtD
Ticlopidine—Sepsis—Fluorouracil—colon cancer	0.00253	0.0112	CcSEcCtD
Ticlopidine—Hepatic failure—Vincristine—colon cancer	0.00252	0.0112	CcSEcCtD
Ticlopidine—MPO—liver—colon cancer	0.00241	0.0117	CbGeAlD
Ticlopidine—Dermatitis exfoliative—Irinotecan—colon cancer	0.00234	0.0104	CcSEcCtD
Ticlopidine—Contusion—Capecitabine—colon cancer	0.00233	0.0104	CcSEcCtD
Ticlopidine—CYP2C8—renal system—colon cancer	0.00231	0.0112	CbGeAlD
Ticlopidine—CYP1A1—epithelium—colon cancer	0.0023	0.0111	CbGeAlD
Ticlopidine—Hyponatraemia—Vincristine—colon cancer	0.00228	0.0101	CcSEcCtD
Ticlopidine—Bone marrow depression—Methotrexate—colon cancer	0.00224	0.00997	CcSEcCtD
Ticlopidine—Hyponatraemia—Irinotecan—colon cancer	0.00222	0.00985	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00221	0.00981	CcSEcCtD
Ticlopidine—Osteoarthritis—Irinotecan—colon cancer	0.00221	0.00981	CcSEcCtD
Ticlopidine—CYP2C19—digestive system—colon cancer	0.00217	0.0105	CbGeAlD
Ticlopidine—CYP1A2—renal system—colon cancer	0.00216	0.0105	CbGeAlD
Ticlopidine—Lung disorder—Methotrexate—colon cancer	0.00214	0.00951	CcSEcCtD
Ticlopidine—CYP1A1—renal system—colon cancer	0.00213	0.0103	CbGeAlD
Ticlopidine—Osteoarthritis—Fluorouracil—colon cancer	0.00211	0.00939	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00211	0.00939	CcSEcCtD
Ticlopidine—CYP2B6—renal system—colon cancer	0.00207	0.01	CbGeAlD
Ticlopidine—Cramp muscle—Irinotecan—colon cancer	0.00199	0.00883	CcSEcCtD
Ticlopidine—Colitis—Capecitabine—colon cancer	0.00195	0.00868	CcSEcCtD
Ticlopidine—CYP2E1—renal system—colon cancer	0.00194	0.00942	CbGeAlD
Ticlopidine—Abdominal distension—Irinotecan—colon cancer	0.00192	0.00853	CcSEcCtD
Ticlopidine—CYP2C19—vagina—colon cancer	0.00192	0.00929	CbGeAlD
Ticlopidine—Pancytopenia—Vincristine—colon cancer	0.00186	0.00827	CcSEcCtD
Ticlopidine—MPO—lymph node—colon cancer	0.00185	0.00896	CbGeAlD
Ticlopidine—Ecchymosis—Capecitabine—colon cancer	0.00184	0.00818	CcSEcCtD
Ticlopidine—Eosinophilia—Fluorouracil—colon cancer	0.00181	0.00804	CcSEcCtD
Ticlopidine—CYP1A2—digestive system—colon cancer	0.00177	0.00859	CbGeAlD
Ticlopidine—Sepsis—Capecitabine—colon cancer	0.00177	0.00785	CcSEcCtD
Ticlopidine—CYP1A1—digestive system—colon cancer	0.00175	0.00847	CbGeAlD
Ticlopidine—Pancytopenia—Fluorouracil—colon cancer	0.00174	0.00771	CcSEcCtD
Ticlopidine—CYP2B6—lymphoid tissue—colon cancer	0.00172	0.00834	CbGeAlD
Ticlopidine—Neuropathy peripheral—Vincristine—colon cancer	0.00171	0.00761	CcSEcCtD
Ticlopidine—CYP2B6—digestive system—colon cancer	0.0017	0.00823	CbGeAlD
Ticlopidine—Diabetes mellitus—Capecitabine—colon cancer	0.0017	0.00755	CcSEcCtD
Ticlopidine—CYP2C9—digestive system—colon cancer	0.00168	0.00815	CbGeAlD
Ticlopidine—CYP2C8—vagina—colon cancer	0.00167	0.00811	CbGeAlD
Ticlopidine—Renal failure—Irinotecan—colon cancer	0.00167	0.00743	CcSEcCtD
Ticlopidine—Vascular purpura—Capecitabine—colon cancer	0.00165	0.00734	CcSEcCtD
Ticlopidine—Hepatic failure—Capecitabine—colon cancer	0.00164	0.0073	CcSEcCtD
Ticlopidine—Haemolytic anaemia—Capecitabine—colon cancer	0.00164	0.00727	CcSEcCtD
Ticlopidine—CYP2C19—liver—colon cancer	0.00162	0.00784	CbGeAlD
Ticlopidine—CYP2E1—lymphoid tissue—colon cancer	0.00161	0.00782	CbGeAlD
Ticlopidine—Neuropathy peripheral—Fluorouracil—colon cancer	0.0016	0.0071	CcSEcCtD
Ticlopidine—CYP2E1—digestive system—colon cancer	0.00159	0.00773	CbGeAlD
Ticlopidine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00157	0.00696	CcSEcCtD
Ticlopidine—CYP3A4—renal system—colon cancer	0.00156	0.00758	CbGeAlD
Ticlopidine—Vasculitis—Methotrexate—colon cancer	0.00155	0.0069	CcSEcCtD
Ticlopidine—CYP1A1—vagina—colon cancer	0.00154	0.00748	CbGeAlD
Ticlopidine—CYP2D6—renal system—colon cancer	0.00154	0.00746	CbGeAlD
Ticlopidine—Epistaxis—Fluorouracil—colon cancer	0.00154	0.00683	CcSEcCtD
Ticlopidine—Haemoglobin—Irinotecan—colon cancer	0.00153	0.00682	CcSEcCtD
Ticlopidine—Purpura—Capecitabine—colon cancer	0.00153	0.00681	CcSEcCtD
Ticlopidine—Haemorrhage—Irinotecan—colon cancer	0.00153	0.00678	CcSEcCtD
Ticlopidine—CYP2B6—vagina—colon cancer	0.0015	0.00727	CbGeAlD
Ticlopidine—Hyponatraemia—Capecitabine—colon cancer	0.00148	0.00659	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00148	0.00656	CcSEcCtD
Ticlopidine—Osteoarthritis—Capecitabine—colon cancer	0.00148	0.00656	CcSEcCtD
Ticlopidine—Haemoglobin—Fluorouracil—colon cancer	0.00147	0.00653	CcSEcCtD
Ticlopidine—Haemorrhage—Fluorouracil—colon cancer	0.00146	0.0065	CcSEcCtD
Ticlopidine—CYP2C8—liver—colon cancer	0.00141	0.00684	CbGeAlD
Ticlopidine—Ecchymosis—Methotrexate—colon cancer	0.00137	0.00609	CcSEcCtD
Ticlopidine—Liver function test abnormal—Capecitabine—colon cancer	0.00136	0.00606	CcSEcCtD
Ticlopidine—CYP1A2—liver—colon cancer	0.00132	0.0064	CbGeAlD
Ticlopidine—Sepsis—Methotrexate—colon cancer	0.00131	0.00584	CcSEcCtD
Ticlopidine—Flatulence—Irinotecan—colon cancer	0.00131	0.00582	CcSEcCtD
Ticlopidine—CYP1A1—liver—colon cancer	0.0013	0.00631	CbGeAlD
Ticlopidine—Abdominal distension—Capecitabine—colon cancer	0.00129	0.00571	CcSEcCtD
Ticlopidine—CYP3A4—digestive system—colon cancer	0.00128	0.00622	CbGeAlD
Ticlopidine—Muscle spasms—Irinotecan—colon cancer	0.00128	0.00568	CcSEcCtD
Ticlopidine—CYP2B6—liver—colon cancer	0.00127	0.00613	CbGeAlD
Ticlopidine—Diabetes mellitus—Methotrexate—colon cancer	0.00126	0.00562	CcSEcCtD
Ticlopidine—CYP2D6—digestive system—colon cancer	0.00126	0.00612	CbGeAlD
Ticlopidine—CYP2C9—liver—colon cancer	0.00125	0.00607	CbGeAlD
Ticlopidine—Hepatic failure—Methotrexate—colon cancer	0.00122	0.00544	CcSEcCtD
Ticlopidine—Pancytopenia—Capecitabine—colon cancer	0.00121	0.00539	CcSEcCtD
Ticlopidine—CYP2E1—liver—colon cancer	0.00119	0.00576	CbGeAlD
Ticlopidine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00117	0.00518	CcSEcCtD
Ticlopidine—Myalgia—Vincristine—colon cancer	0.00116	0.00516	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00113	0.00501	CcSEcCtD
Ticlopidine—Renal failure—Capecitabine—colon cancer	0.00112	0.00497	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Capecitabine—colon cancer	0.00112	0.00496	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vincristine—colon cancer	0.00111	0.00495	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—colon cancer	0.0011	0.00489	CcSEcCtD
Ticlopidine—Thrombocytopenia—Vincristine—colon cancer	0.00109	0.00485	CcSEcCtD
Ticlopidine—Haematuria—Capecitabine—colon cancer	0.00109	0.00482	CcSEcCtD
Ticlopidine—Anaphylactic shock—Irinotecan—colon cancer	0.00109	0.00482	CcSEcCtD
Ticlopidine—Myalgia—Fluorouracil—colon cancer	0.00108	0.00482	CcSEcCtD
Ticlopidine—Epistaxis—Capecitabine—colon cancer	0.00107	0.00477	CcSEcCtD
Ticlopidine—Thrombocytopenia—Irinotecan—colon cancer	0.00106	0.00472	CcSEcCtD
Ticlopidine—Anorexia—Vincristine—colon cancer	0.00106	0.00472	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fluorouracil—colon cancer	0.00104	0.00462	CcSEcCtD
Ticlopidine—Anorexia—Irinotecan—colon cancer	0.00103	0.00459	CcSEcCtD
Ticlopidine—Haemoglobin—Capecitabine—colon cancer	0.00103	0.00456	CcSEcCtD
Ticlopidine—Haemorrhage—Capecitabine—colon cancer	0.00102	0.00454	CcSEcCtD
Ticlopidine—Hepatitis—Capecitabine—colon cancer	0.00102	0.00454	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fluorouracil—colon cancer	0.00102	0.00452	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—colon cancer	0.00102	0.00451	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00102	0.00451	CcSEcCtD
Ticlopidine—CYP1A1—lymph node—colon cancer	0.000999	0.00484	CbGeAlD
Ticlopidine—Anorexia—Fluorouracil—colon cancer	0.000991	0.0044	CcSEcCtD
Ticlopidine—Decreased appetite—Vincristine—colon cancer	0.000969	0.0043	CcSEcCtD
Ticlopidine—Erythema multiforme—Capecitabine—colon cancer	0.000966	0.00429	CcSEcCtD
Ticlopidine—CYP3A4—liver—colon cancer	0.000956	0.00463	CbGeAlD
Ticlopidine—Dyspepsia—Irinotecan—colon cancer	0.000955	0.00424	CcSEcCtD
Ticlopidine—Tinnitus—Capecitabine—colon cancer	0.000953	0.00423	CcSEcCtD
Ticlopidine—Pain—Vincristine—colon cancer	0.000953	0.00423	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000947	0.00421	CcSEcCtD
Ticlopidine—Decreased appetite—Irinotecan—colon cancer	0.000943	0.00419	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—colon cancer	0.000941	0.00418	CcSEcCtD
Ticlopidine—CYP2D6—liver—colon cancer	0.000941	0.00456	CbGeAlD
Ticlopidine—Pain—Irinotecan—colon cancer	0.000928	0.00412	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—colon cancer	0.000915	0.00406	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vincristine—colon cancer	0.000911	0.00405	CcSEcCtD
Ticlopidine—Decreased appetite—Fluorouracil—colon cancer	0.000903	0.00401	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—colon cancer	0.000903	0.00401	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—colon cancer	0.000889	0.00395	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Irinotecan—colon cancer	0.000887	0.00394	CcSEcCtD
Ticlopidine—Body temperature increased—Vincristine—colon cancer	0.000881	0.00391	CcSEcCtD
Ticlopidine—Flatulence—Capecitabine—colon cancer	0.000877	0.00389	CcSEcCtD
Ticlopidine—Body temperature increased—Irinotecan—colon cancer	0.000858	0.00381	CcSEcCtD
Ticlopidine—Muscle spasms—Capecitabine—colon cancer	0.000855	0.0038	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00084	0.00373	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—colon cancer	0.000833	0.0037	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—colon cancer	0.000826	0.00367	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—colon cancer	0.000822	0.00365	CcSEcCtD
Ticlopidine—Hypersensitivity—Vincristine—colon cancer	0.000821	0.00365	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—colon cancer	0.000808	0.00359	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—colon cancer	0.000799	0.00355	CcSEcCtD
Ticlopidine—Hypersensitivity—Irinotecan—colon cancer	0.000799	0.00355	CcSEcCtD
Ticlopidine—Asthenia—Vincristine—colon cancer	0.000799	0.00355	CcSEcCtD
Ticlopidine—Asthenia—Irinotecan—colon cancer	0.000778	0.00346	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—colon cancer	0.000766	0.0034	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—colon cancer	0.000765	0.0034	CcSEcCtD
Ticlopidine—Diarrhoea—Vincristine—colon cancer	0.000762	0.00339	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—colon cancer	0.000761	0.00338	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—colon cancer	0.000761	0.00338	CcSEcCtD
Ticlopidine—Myalgia—Capecitabine—colon cancer	0.000758	0.00337	CcSEcCtD
Ticlopidine—Arthralgia—Capecitabine—colon cancer	0.000758	0.00337	CcSEcCtD
Ticlopidine—Diarrhoea—Irinotecan—colon cancer	0.000742	0.0033	CcSEcCtD
Ticlopidine—Dizziness—Vincristine—colon cancer	0.000737	0.00327	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—colon cancer	0.000735	0.00327	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—colon cancer	0.000719	0.0032	CcSEcCtD
Ticlopidine—Dizziness—Irinotecan—colon cancer	0.000718	0.00319	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—colon cancer	0.000711	0.00316	CcSEcCtD
Ticlopidine—Thrombocytopenia—Capecitabine—colon cancer	0.000711	0.00316	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—colon cancer	0.000709	0.00315	CcSEcCtD
Ticlopidine—Vomiting—Vincristine—colon cancer	0.000708	0.00315	CcSEcCtD
Ticlopidine—Rash—Vincristine—colon cancer	0.000702	0.00312	CcSEcCtD
Ticlopidine—Dermatitis—Vincristine—colon cancer	0.000702	0.00312	CcSEcCtD
Ticlopidine—Headache—Vincristine—colon cancer	0.000698	0.0031	CcSEcCtD
Ticlopidine—Anorexia—Capecitabine—colon cancer	0.000692	0.00308	CcSEcCtD
Ticlopidine—Vomiting—Irinotecan—colon cancer	0.00069	0.00306	CcSEcCtD
Ticlopidine—Dizziness—Fluorouracil—colon cancer	0.000687	0.00305	CcSEcCtD
Ticlopidine—Rash—Irinotecan—colon cancer	0.000684	0.00304	CcSEcCtD
Ticlopidine—Dermatitis—Irinotecan—colon cancer	0.000684	0.00304	CcSEcCtD
Ticlopidine—Headache—Irinotecan—colon cancer	0.00068	0.00302	CcSEcCtD
Ticlopidine—Nausea—Vincristine—colon cancer	0.000662	0.00294	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000662	0.00294	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—colon cancer	0.000661	0.00294	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—colon cancer	0.000655	0.00291	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—colon cancer	0.000655	0.00291	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—colon cancer	0.000651	0.00289	CcSEcCtD
Ticlopidine—Nausea—Irinotecan—colon cancer	0.000645	0.00286	CcSEcCtD
Ticlopidine—Dyspepsia—Capecitabine—colon cancer	0.000639	0.00284	CcSEcCtD
Ticlopidine—Decreased appetite—Capecitabine—colon cancer	0.000631	0.0028	CcSEcCtD
Ticlopidine—Pain—Capecitabine—colon cancer	0.000621	0.00276	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—colon cancer	0.000617	0.00274	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Capecitabine—colon cancer	0.000594	0.00264	CcSEcCtD
Ticlopidine—Urticaria—Capecitabine—colon cancer	0.000577	0.00256	CcSEcCtD
Ticlopidine—Body temperature increased—Capecitabine—colon cancer	0.000574	0.00255	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—colon cancer	0.000564	0.00251	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—colon cancer	0.000564	0.00251	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—colon cancer	0.000541	0.0024	CcSEcCtD
Ticlopidine—Hypersensitivity—Capecitabine—colon cancer	0.000535	0.00238	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—colon cancer	0.000529	0.00235	CcSEcCtD
Ticlopidine—Asthenia—Capecitabine—colon cancer	0.000521	0.00231	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—colon cancer	0.000515	0.00229	CcSEcCtD
Ticlopidine—Pruritus—Capecitabine—colon cancer	0.000514	0.00228	CcSEcCtD
Ticlopidine—Diarrhoea—Capecitabine—colon cancer	0.000497	0.00221	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000493	0.00219	CcSEcCtD
Ticlopidine—Dizziness—Capecitabine—colon cancer	0.00048	0.00213	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—colon cancer	0.000476	0.00211	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—colon cancer	0.00047	0.00209	CcSEcCtD
Ticlopidine—Pain—Methotrexate—colon cancer	0.000462	0.00205	CcSEcCtD
Ticlopidine—Vomiting—Capecitabine—colon cancer	0.000462	0.00205	CcSEcCtD
Ticlopidine—Rash—Capecitabine—colon cancer	0.000458	0.00203	CcSEcCtD
Ticlopidine—Dermatitis—Capecitabine—colon cancer	0.000457	0.00203	CcSEcCtD
Ticlopidine—Headache—Capecitabine—colon cancer	0.000455	0.00202	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—colon cancer	0.000442	0.00196	CcSEcCtD
Ticlopidine—Nausea—Capecitabine—colon cancer	0.000431	0.00192	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—colon cancer	0.000429	0.00191	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—colon cancer	0.000427	0.0019	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—colon cancer	0.000398	0.00177	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—colon cancer	0.000388	0.00172	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—colon cancer	0.000382	0.0017	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—colon cancer	0.00037	0.00164	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—colon cancer	0.000357	0.00159	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—colon cancer	0.000344	0.00153	CcSEcCtD
Ticlopidine—Rash—Methotrexate—colon cancer	0.000341	0.00151	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—colon cancer	0.000341	0.00151	CcSEcCtD
Ticlopidine—Headache—Methotrexate—colon cancer	0.000339	0.0015	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—colon cancer	0.000321	0.00143	CcSEcCtD
